Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDH1 | O75874 | 4/20 | 0.35 |
| ▸ | PTGES | O14684 | 2/20 | 0.34 |
| ▸ | GFER | P55789 | 1/20 | 0.32 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL578318 | 0.86 | IDH1 (0.36) | IDH1PTGESLMNAPOLB | |
| SCHEMBL578140 | 0.81 | LMNA (0.35) | IDH1PTGESLMNAPOLB | |
| SCHEMBL578086 | 0.80 | IDH1 (0.36) | IDH1PTGESGFERCYP19A1LMNA | |
| SCHEMBL577784 | 0.80 | IDH1 (0.36) | IDH1PTGESGFERCYP19A1LMNA | |
| SCHEMBL11905052 | 0.79 | IDH1 (0.42) | IDH1PTGESCYP19A1LMNAPOLB | |
| SCHEMBL577653 | 0.79 | KDM4E (0.37) | IDH1PTGESGFERCYP19A1LMNA | |
| SCHEMBL578009 | 0.79 | OPRM1 (0.40) | IDH1GFERLMNA | |
| SCHEMBL15215579 | 0.78 | ALDH1A1 (0.43) | IDH1PTGESGFERLMNAPOLB | |
| SCHEMBL577698 | 0.78 | PDE10A (0.39) | IDH1PTGESLMNAPOLBNTRK1 | |
| SCHEMBL577994 | 0.78 | PTGES (0.35) | IDH1PTGESCYP19A1LMNANTRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2461811-A1 | MACROCYCLIC SERINE PROTEASE INHIBITORS USEFUL AGAINST VIRAL INFECTIONS, PARTICULARLY HCV | IDENIX Pharmaceuticals, Inc. (US) | 2012-06-13 | — | — | EP | disclosed |
| EP-2417134-A1 | MACROCYCLIC SERINE PROTEASE INHIBITORS | IDENIX Pharmaceuticals, Inc. (US) | 2012-02-15 | — | — | EP | disclosed |
| WO-2011017389-A1 | MACROCYCLIC SERINE PROTEASE INHIBITORS USEFUL AGAINST VIRAL INFECTIONS, PARTICULARLY HCV | IDENIX PHARMACEUTICALS, INC. (US) | 2011-02-10 | — | — | WO | disclosed |
| WO-2010118078-A1 | MACROCYCLIC SERINE PROTEASE INHIBITORS | IDENIX PHARMACEUTICALS, INC. (US) | 2010-10-14 | — | — | WO | disclosed |